| Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 10.02B | 10.14B | 9.96B | 9.68B | 13.24B |
| Gross Profit | 5.57B | 5.36B | 5.12B | 5.21B | 5.74B |
| EBITDA | 1.52B | 1.35B | 1.30B | 1.46B | 2.04B |
| Net Income | 725.81M | 401.91M | 82.32M | 391.70M | 984.30M |
Balance Sheet | |||||
| Total Assets | 14.48B | 13.97B | 13.78B | 13.53B | 12.79B |
| Cash, Cash Equivalents and Short-Term Investments | 6.11B | 6.97B | 6.58B | 6.35B | 5.52B |
| Total Debt | 12.35M | 10.10M | 13.08M | 12.59M | 23.98M |
| Total Liabilities | 6.62B | 6.55B | 6.48B | 6.04B | 6.76B |
| Stockholders Equity | 7.86B | 7.42B | 7.29B | 7.49B | 6.03B |
Cash Flow | |||||
| Free Cash Flow | 1.44B | 680.39M | 719.45M | -220.95M | 1.85B |
| Operating Cash Flow | 1.74B | 1.19B | 1.34B | 515.07M | 2.43B |
| Investing Cash Flow | -2.15B | -523.03M | -2.01B | -2.21B | -653.23M |
| Financing Cash Flow | -287.80M | -286.14M | -285.94M | 1.12B | -178.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥8.60B | 10.01 | ― | 1.24% | 11.42% | 29.26% | |
74 Outperform | ¥5.56B | 11.52 | ― | 4.65% | 5.94% | 617.63% | |
71 Outperform | ¥8.04B | 9.57 | ― | 3.62% | -0.94% | 51.68% | |
63 Neutral | ¥3.55B | 563.91 | ― | ― | 9.93% | -81.98% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
59 Neutral | ¥8.96B | 12.89 | ― | 2.61% | 11.84% | 246.10% | |
57 Neutral | ¥13.93B | 29.59 | ― | 7.85% | -3.20% | 34.08% |